Success Metrics

Clinical Success Rate
90.6%

Based on 173 completed trials

Completion Rate
91%(173/191)
Active Trials
18(7%)
Results Posted
51%(89 trials)
Terminated
18(7%)

Phase Distribution

Ph phase_2
41
17%
Ph phase_4
73
29%
Ph phase_1
12
5%
Ph phase_3
70
28%
Ph early_phase_1
3
1%
Ph not_applicable
38
15%

Phase Distribution

15

Early Stage

41

Mid Stage

143

Late Stage

Phase Distribution237 total trials
Early Phase 1First-in-human
3(1.3%)
Phase 1Safety & dosage
12(5.1%)
Phase 2Efficacy & side effects
41(17.3%)
Phase 3Large-scale testing
70(29.5%)
Phase 4Post-market surveillance
73(30.8%)
N/ANon-phased studies
38(16.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.2%

173 of 203 finished

Non-Completion Rate

14.8%

30 ended early

Currently Active

18

trials recruiting

Total Trials

248

all time

Status Distribution
Active(21)
Completed(173)
Terminated(30)
Other(24)

Detailed Status

Completed173
unknown24
Terminated18
Recruiting16
Withdrawn12
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
248
Active
18
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (1.3%)
Phase 112 (5.1%)
Phase 241 (17.3%)
Phase 370 (29.5%)
Phase 473 (30.8%)
N/A38 (16.0%)

Trials by Status

enrolling_by_invitation10%
active_not_recruiting21%
unknown2410%
recruiting166%
completed17370%
terminated187%
withdrawn125%
not_yet_recruiting21%

Recent Activity

Clinical Trials (248)

Showing 20 of 248 trialsScroll for more
NCT07431606Phase 2

Duloxetine in Inflammatory Bowel Diseases

Not Yet Recruiting
NCT06245109Phase 4

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT06614322Phase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Recruiting
NCT04504812Phase 3

A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain

Completed
NCT05840562Phase 3

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Recruiting
NCT06807866Phase 4

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

Recruiting
NCT07326163Not Applicable

The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients

Enrolling By Invitation
NCT05814640Phase 1

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Recruiting
NCT04137107Phase 2

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Active Not Recruiting
NCT04560673Phase 2

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Recruiting
NCT06423716Phase 4

Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)

Recruiting
NCT04870957Phase 4

The Back Pain Consortium Research Program Study

Completed
NCT05851976Phase 4

Duloxetine for LBP

Recruiting
NCT06860984Phase 3

Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Recruiting
NCT05086393Phase 4

Duloxetine RCT on Postop TKA Outcomes

Completed
NCT03548454Phase 4

Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization

Completed
NCT04395001Phase 4

Pain Response Evaluation of a Combined Intervention to Cope Effectively

Completed
NCT04111627Phase 2

Exercise Plus Duloxetine for Knee Osteoarthritis

Completed
NCT06087211Not Applicable

Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain

Completed

Drug Details

Intervention Type
DRUG
Total Trials
248